Bring-your-own-devices offer trial benefits

The rise in the use of global communications technology has had a profound effect on clinical and late phase trials, and how contract research organisations (CROs) and sponsors approach the retention of patients and adherence to medication regimens.

The globalisation of clinical trials, however, also poses challenges. Language barriers, cultural differences and a lack of access to healthcare professionals (HCPs) in certain regions presents new issues which need to be overcome, and it has been a concern that some patients have felt they are not fully supported during the trial; a common reason for patient dropoff, and, in turn, trial failure.

In the clinical trials environment, engagement now goes well beyond simple reminders. To ensure patient adherence to medication regimes, retention throughout the trial duration and ultimately, better patient outcomes, sponsors and CROs are creating a more patient-centric trial approach. It is known that electronic patient reported outcome (ePRO) data collection has transformed patient engagement but until recently, collecting ePRO data was limited to the use of provisioned devices. The use of device independent technology has opened the door to a more cost effective model: Bring Your Own Device (BYOD).